Andres M. Salazar, MD
Founder, CEO & Scientific Director
Dr. Andres M. Salazar, MD, is Chairman, CEO, Scientific Director and cofounder of Oncovir, Inc, a small pharmaceutical company developing the potent immunomodulator, Hiltonol® (Poly-ICLC). Dr. Salazar was formerly Professor of Neurology at the Uniformed Services University in Bethesda, Maryland and is a retired US Army Colonel. He was director of the Vietnam Head Injury Study and Founder, Principal Investigator, and first Director of the Defense and Veterans Head Injury Program, a national head injury disease management and clinical research effort. His research background includes neurodegenerative diseases, multiple sclerosis (MS), AIDS, neurooncology, and neurotraumatology. He is author on over 250 publications and presentations, and has conducted numerous clinical studies, including in head injury, AIDS, early and later pivotal clinical studies of beta-interferon (Avonex) in multiple sclerosis, and pilot studies of Hiltonol® in brain tumors, MS, and AIDS. Dr. Salazar is a graduate of Dartmouth College and Jefferson Medical College. He completed Neurology training at Walter Reed Army Medical Center, and a Neurovirology Fellowship at the CNSSL, National Institutes of Health, Bethesda, Md.
Matthew A. Vandermast
Mr. Vandermast is an accomplished senior sales and business development executive with more than 20 years of experience in business strategy execution in both large and small companies. He is a consistent top performer in sales management and operations leading full sales and project implementation life cycles. Mr. Vandermast has extensive experience in managing complex projects in data analytics, software development and enterprise IT integration. As an innovative, decisive leader with success in strategic business planning, development and implementation, he has been involved in M&A life cycles and company integrations into new operating environments. Mr. Vandermast has extensive experience building business unit operations, sales infrastructure, product development, and sales/marketing strategies to optimize revenue, profit, client/partner engagement and market share. Mr. Vandermast holds an MBA degree from Purdue University and a BS in Engineering from Clarkson University.
Vikas Moolchandani, PhD
VP of CMC and Product Development
Rose Marie Holman
Director of Clinical Development & Clinical Trials Manager
Esteban Celis, MD, PhD